Stem cell therapy successfully treats heart attack in animals

July 26, 2005

Two patients enrolled in Phase I clinical trials at Hopkins

Final results of a study conducted at Johns Hopkins show that stem cell therapy can be used effectively to treat heart attacks, or myocardial infarction, in pigs. In just two months, stem cells harvested from another pig's bone marrow and injected into the animal's damaged heart restored heart function and repaired damaged heart muscle by 50 percent to 75 percent.

The Hopkins findings, first presented last fall at the 2004 Scientific Sessions of the American Heart Association, are to be published in the latest issue of the Proceedings of the National Academy of Sciences online the week of July 25.

Two patients have already been enrolled at Hopkins in a Phase I clinical trial, which is designed to test the safety of injecting adult stem cells at varying doses in patients who have recently suffered a heart attack. In total, 48 patients will participate in this study, which is happening at several sites across the country. Results are not expected until mid-2006.

"Ultimately, the goal is to develop a widely applicable treatment to repair and reverse the damage done to heart muscle that has been infarcted, or destroyed, after losing its blood supply," says cardiologist Joshua Hare, M.D., professor of medicine at The Johns Hopkins University School of Medicine and its Heart Institute, and senior author of the study and lead trial investigator.

"There is reason for optimism about these findings, possibly leading to a first-ever cure for heart attack in humans," he says. "If a treatment can be found for the damage done by a heart attack to heart muscle, then there is the potential to forestall the serious complications that traditionally result from a heart attack, including disturbances of heart rhythm that can lead to sudden cardiac death, and decreased muscle pumping function that can lead to congestive heart failure."

The researchers are using a special kind of stem cell in an early stage of development, called adult mesenchymal stem cells, to avoid potential problems with immunosuppression, in which every human's immune system might attack stem cells from sources other than itself. Bone marrow adult stem cells do not have the same potential to develop into different organ tissues, as do embryonic stem cells, whose use is more controversial.

Johns Hopkins Medical Institutions

---

---

	Umbilical Cord Stem Cell Therapy: The Gift of Healing from Healthy Newborns by Anthony G. Payne (Author), David Steenblock (Author) We are standing at the threshold of a new and exciting medical era-an era of regeneration, rejuvenation, and renewal in which stems cells will set the stage for healing and in some cases, the restoration of injured, diseased, and debilitated tissues and organ. While stem cell therapy is still in its infancy, the field is rich with promise. The debate over the use of embryonic stem cells and the questionable effectiveness of adult stem cells have led many scientists and clinicians to concentrate their energies on umbilical-cord-derived stem cells from healthy newborn babies. While these cells are technically classifed as "adult stem cells," they appear to have greater restorative and regenerative potential than stem cells derived from adult tissues due to their young age. Human...
	Stem Cells For Dummies by Lawrence S.B. Goldstein (Author), Meg Schneider (Author) The first authoritative yet accessible guide to this controversial topicStem Cell Research For Dummies offers a balanced, plain-English look at this politically charged topic, cutting away the hype and presenting the facts clearly for you, free from debate. It explains what stem cells are and what they do, the legalities of harvesting them and using them in research, the latest research findings from the U.S. and abroad, and the prospects for medical stem cell therapies in the short and long term.Explains the differences between adult stem cells and embryonic/umbilical cord stem cellsProvides both sides of the political debate and the pros and cons of each side's opinionsIncludes medical success stories using stem cell therapy and its promise for the futureComprehensive and unbiased, Stem...
	Stem Cell Therapy and Uses in Medical Treatment (Stem Cells- Laboratory and Clinical Research) by Prasad S. Koka (Editor) This book presents and discusses current research in the study of stem cell therapy. Topics discussed include stem cell-based therapies; current therapies for multiple sclerosis; stem cell transplantation modulates mRNA gene expression profile in doxorubicin-induced cardiomyopathy; human somatic cell nuclear transfer and parthenogenesis; human cord blood stem cell applications in cell therapy; and, cancer stem cells and neurotrophin in obstetrics and gynaecology.
	Stem Cell Therapy and Tissue Engineering for Cardiovascular Repair: From Basic Research to Clinical Applications by Nabil Dib (Editor), Doris A. Taylor (Editor), Edward B. Diethrich (Editor) In excess of 7 million people worldwide die of coronary heart disease each year.  Only one-third of these heart attack victims recover completely.  The remainder suffer the consequences of myocardial infarction and its ill fated remodeling process, resulting in chronic congestive heart failure.  This malady alone is the leading cause of hospital admissions in the United States. New breakthroughs in stem cell therapy and tissue engineering have promised to reverse this dismal outcome by cardiovascular repair.  World authorities, including scientists and regulatory authorities, have joined in a collaborative effort to present for the reader the first collective review of stem cell therapy for the treatment of cardiovascular disease.  These contributions in basic science, pre-clinical...
	Stem Cell Therapy for Diabetes (Stem Cell Biology and Regenerative Medicine) by Shimon Efrat (Editor) Stem Cell Therapy for Diabetes, one of the latest installments of the Stem Cell Biology and Regenerative Medicine series, reviews the three main approaches for generation of sufficient numbers of insulin-producing cells for restoration of an adequate beta-cell mass: beta-cell expansion, stem-cell differentiation, and nuclear reprogramming. Adeptly collecting the research of the leading scientists in the field, Stem Cell Therapy for Diabetes compares the merits of employing autologous versus banked allogeneic cell sources for generation of surrogate beta cells, and addresses tissue engineering and ways for cell protection from recurring autoimmunity and graft rejection. Stem Cell Therapy for Diabetes provides essential reading for those especially interested in tracking the progress in...
	Embryonic Stem Cell Therapy for Osteo-Degenerative Diseases: Methods and Protocols (Methods in Molecular Biology) by Nicole I. Nieden (Editor) Embryonic stem cells (ESCs) offer an unlimited self-renewing capacity, as opposed to the limits of adult stem cells; therefore, ESCs represent an almost bottomless resource for regenerative medicine and tissue engineering approaches. In Embryonic Stem Cell Therapy for Osteo-Degenerative Diseases: Methods and Protocols, accomplished investigators provide detailed descriptions on how to expand ESCs from the most commonly used species ex vivo, i.e. mouse and human, in static culture as well as in controllable bioreactor processes. The thorough and timely volume summarizes the methods that may be used to differentiate these cells along the desired lineage of choice, be it osteoblasts, osteoclasts, or chondrocytes, and consequentially also offers analysis tools for the characterization of...
	Artificial Cells: Biotechnology, Nanomedicine, Regenerative Medicine, Blood Substitutes, Bioencapsulation, and Cell/Stem Cell Therapy (Regenerative Medicine, Artificial Cells and Nanomedicine) by Thomas Ming Swi Chang (Author) This is the first book that provides a comprehensive review of the entire area of artificial cells. The author, a pioneer of the field, invented the first artificial cells some 50 years ago and has continued to carry out active research in this field. Since then, there have been explosive research activities around the world on artificial cells, especially in fields related to biotechnology, nanomedicine, cell therapy, blood substitutes, drug delivery and others. However, instead of the term artificial cells, many authors use other terminologies such blood substitutes, bioencapsulation, liposomes, nanoparticles, and so on. As a result, any meaningful literature search for a complete idea of the present status of the whole field of artificial cells is impossible. Furthermore, the fact...
	Handbook Of Cardiac Stem Cell Therapy by Ioannis Dimarakis (Author) This book is an impressive compilation of contributions on the hot topic of cardiac stem cell therapy from leading groups all over the world. In the assembly of chapters, a structured approach is adopted; starting from the clinician's perspective, all developments in both the experimental and clinical research areas are covered. This journey will take the reader from the bench-top to the bedside, with all chapters written by leading authorities in their respective fields, including data still in press with medical journals. So, beyond being excellent as an overall update for scientists in the field of cardiac stem cell therapy, this book will likely prove an indispensable tool for every budding scientist considering a research project within this field. Contents: The Meritocracy of Stem...
	Stem Cell Therapy for Autoimmune Disease by Alberto M. Marmont (Author), Alberto M. Marmont (Editor), Richard K. Burt (Editor)
	Becoming Immortal: Combining Cloning and Stem-Cell Therapy by Stanley Shostak (Author) Explores how new organs might be engineered via cloning and reproductive technology to produce human immortality.